Literature DB >> 20141519

Facts, fancies and follies of drug-induced QT/QTc interval shortening.

Marek Malik1.   

Abstract

Mesh：

Year:  2010        PMID： 20141519      PMCID： PMC2823353          DOI： 10.1111/j.1476-5381.2009.00554.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  47 in total

1.  QRS and QTc interval prolongation in the prediction of long-term mortality of patients with acute destabilised heart failure.

Authors:  Tobias Breidthardt; Michael Christ; Miriam Matti; Delia Schrafl; Kirsten Laule; Markus Noveanu; Tujana Boldanova; Theresia Klima; Willibald Hochholzer; André P Perruchoud; Christian Mueller
Journal:  Heart       Date:  2007-03-29       Impact factor: 5.994

2.  Electrocardiographic correlates with left ventricular morphology in idiopathic dilated cardiomyopathy.

Authors:  F Pelliccia; G Critelli; C Cianfrocca; A Nigri; A Reale
Journal:  Am J Cardiol       Date:  1991-09-01       Impact factor: 2.778

3.  Atorvastatin therapy increases heart rate variability, decreases QT variability, and shortens QTc interval duration in patients with advanced chronic heart failure.

Authors:  Bojan Vrtovec; Renata Okrajsek; Alenka Golicnik; Mateja Ferjan; Vito Starc; Branislav Radovancevic
Journal:  J Card Fail       Date:  2005-12       Impact factor: 5.712

Review 4.  Drug-induced QT interval shortening: potential harbinger of proarrhythmia and regulatory perspectives.

Authors:  Rashmi R Shah
Journal:  Br J Pharmacol       Date:  2009-06-25       Impact factor: 8.739

5.  Changes in the arterial blood pressure, heart rate and normal ECG parameters of rat after envenomation with Egyptian cobra (Naja haje) venom.

Authors:  M A Omran; I M Abdel-Nabi
Journal:  Hum Exp Toxicol       Date:  1997-06       Impact factor: 2.903

6.  Effects of thyroid hormone deficiency on electrocardiogram findings of congenitally hypothyroid neonates.

Authors:  T Asami; H Suzuki; S Yazaki; S Sato; M Uchiyama
Journal:  Thyroid       Date:  2001-08       Impact factor: 6.568

7.  Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984.

Authors:  M B Codd; D D Sugrue; B J Gersh; L J Melton
Journal:  Circulation       Date:  1989-09       Impact factor: 29.690

8.  Amlodipine in ischaemic left ventricular dysfunction with mild to moderate heart failure.

Authors:  G P Perna; G Valle; N Cianfrone; G D Luca; C Amico; C Coli
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

9.  Quinidine syncope: torsade de pointes with low quinidine plasma concentrations.

Authors:  H R Jenzer; F Hagemeijer
Journal:  Eur J Cardiol       Date:  1976-12

10.  Linearly scaled, rate-invariant normal limits for QT interval: eight decades of incorrect application of power functions.

Authors:  Pentti M Rautaharju; Zhu-Ming Zhang
Journal:  J Cardiovasc Electrophysiol       Date:  2002-12
View more
  8 in total

1.  Novel targets and regulatory ordeal by QT interval.

Authors:  J M Ritter
Journal:  Br J Clin Pharmacol       Date:  2010-04       Impact factor: 4.335

Review 2.  Thorough QT Studies: Questions and Quandaries.

Authors:  Marek Malik; Christine E Garnett; Joanne Zhang
Journal:  Drug Saf       Date:  2010-01-01       Impact factor: 5.606

3.  Reducing QT liability and proarrhythmic risk in drug discovery and development.

Authors:  Jean-Pierre Valentin
Journal:  Br J Pharmacol       Date:  2010-01       Impact factor: 8.739

4.  Pharmacological and electrophysiological characterization of AZSMO-23, an activator of the hERG K(+) channel.

Authors:  R Mannikko; M H Bridgland-Taylor; H Pye; S Swallow; N Abi-Gerges; M J Morton; C E Pollard
Journal:  Br J Pharmacol       Date:  2015-04-10       Impact factor: 8.739

Review 5.  Drug-Induced QT/QTc Interval Shortening: Lessons from Drug-Induced QT/QTc Prolongation.

Authors:  Marek Malik
Journal:  Drug Saf       Date:  2016-07       Impact factor: 5.606

6.  The DPP-4 inhibitor linagliptin does not prolong the QT interval at therapeutic and supratherapeutic doses.

Authors:  Arne Ring; Andreas Port; E Ulrike Graefe-Mody; Ivette Revollo; Mario Iovino; Klaus A Dugi
Journal:  Br J Clin Pharmacol       Date:  2011-07       Impact factor: 4.335

7.  A thorough QTc study to evaluate the effects of oral rilzabrutinib administered alone and with ritonavir in healthy subjects.

Authors:  Sibel Ucpinar; Borje Darpo; Ann Neale; Philip Nunn; Jin Shu; Katherine A Chu; Marianne Kavanagh; Hongqi Xue; Pasit Phiasivongsa; Dolca Thomas; Patrick F Smith
Journal:  Clin Transl Sci       Date:  2022-04-03       Impact factor: 4.438

8.  Mapping the Knowledge of Antipsychotics-Induced Sudden Cardiac Death: A Scientometric Analysis in CiteSpace and VOSviewer.

Authors:  Min Wang; Yixun Ma; Zefang Shen; Lufang Jiang; Xiaoyuan Zhang; Xuan Wei; Zhengqi Han; Hongxia Liu; Tiantong Yang
Journal:  Front Psychiatry       Date:  2022-07-07       Impact factor: 5.435
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.